Rexahn Pharmaceuticals Inc (NYSE American:RNN)

2.28
Delayed Data
As of May 21
 -0.10 / -4.20%
Today’s Change
1.42
Today|||52-Week Range
4.37
+12.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-18.5M-14.4M-9.3M-25.3M
 
 
 
 
 
Depreciation28.3K27.5K32.9K42.4K
 
 
 
 
 
Total Other Cash Flow6.2M-2.7M-3.8M9.2M
 
 
 
 
 
Funds From Operations-12.3M-17.1M-13.1M-16.1M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.3M293.9K165.5K-655.4K
 
 
 
 
 
Net Cash Flow - Operating Activities-11.0M-17.4M-13.2M-15.4M
 
 
 
 
 
 
InvestingIncrease In Investments-26.1M-7.9M-8.7M-21.0M
 
 
 
 
 
Decrease In Investments3.5M17.5M13.2M11.7M
 
 
 
 
 
Capital Expenditures-41.2K-62.3K-8.7K-75.2K
 
 
 
 
 
Net Cash Flow Investing-22.7M9.6M4.5M-9.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale24.8M8.2M10.1M22.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing24.8M8.2M10.1M22.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-8.9M373.2K1.4M-2.7M